Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1974 3
1976 1
1977 1
1979 1
1982 2
1985 1
1991 1
1995 2
1996 2
1997 2
1998 2
1999 8
2000 6
2001 10
2002 14
2003 8
2004 16
2005 20
2006 27
2007 26
2008 28
2009 28
2010 34
2011 42
2012 35
2013 29
2014 24
2015 33
2016 33
2017 37
2018 42
2019 52
2020 85
2021 82
2022 83
2023 96
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

833 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer.
Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, Li M, Lu J, Zhu K, Chu Y, Ding W, Zhu J, Lin Z, Zhong L, Wang J, Yue P, Turkson J, Liu P, Wang Y, Zhang X. Ouyang S, et al. Among authors: yue p. Redox Biol. 2022 Jun;52:102317. doi: 10.1016/j.redox.2022.102317. Epub 2022 Apr 21. Redox Biol. 2022. PMID: 35483272 Free PMC article.
Synthetic lethality between TP53 and ENDOD1.
Tang Z, Zeng M, Wang X, Guo C, Yue P, Zhang X, Lou H, Chen J, Mu D, Kong D, Carr AM, Liu C. Tang Z, et al. Among authors: yue p. Nat Commun. 2022 May 23;13(1):2861. doi: 10.1038/s41467-022-30311-w. Nat Commun. 2022. PMID: 35606358 Free PMC article.
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators. Connolly SJ, et al. Among authors: yue p. N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7. N Engl J Med. 2019. PMID: 30730782 Free PMC article.
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Demchuk AM, Yue P, Zotova E, Nakamya J, Xu L, Milling TJ Jr, Ohara T, Goldstein JN, Middeldorp S, Verhamme P, Lopez-Sendon JL, Conley PB, Curnutte JT, Eikelboom JW, Crowther M, Connolly SJ; ANNEXA-4 Investigators. Demchuk AM, et al. Among authors: yue p. Stroke. 2021 Jun;52(6):2096-2105. doi: 10.1161/STROKEAHA.120.030565. Epub 2021 May 10. Stroke. 2021. PMID: 33966491 Free PMC article. Clinical Trial.
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleeding.
Cohen AT, Lewis M, Connor A, Connolly SJ, Yue P, Curnutte J, Alikhan R, MacCallum P, Tan J, Green L. Cohen AT, et al. Among authors: yue p. J Am Coll Emerg Physicians Open. 2022 Mar 5;3(2):e12655. doi: 10.1002/emp2.12655. eCollection 2022 Apr. J Am Coll Emerg Physicians Open. 2022. PMID: 35280921 Free PMC article.
833 results